X

$XRTX

2 articles found
1 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

XORTX Shareholders Back 5-to-1 Consolidation to Avert NASDAQ Delisting

XORTX shareholders approved a 5-to-1 share consolidation to maintain NASDAQ compliance, reducing shares from 6.96M to 1.39M ahead of April 2026 deadline.
XRTXkidney diseaseshare consolidation
GlobeNewswire Inc.GlobeNewswire Inc.··Xortx Therapeutics Inc.

XORTX Wins ISS Backing for Share Consolidation Plan Ahead of March Vote

XORTX Therapeutics secures ISS endorsement for share consolidation, with proxy advisor backing March 2026 shareholder vote. ISS cited no direct shareholder value impact while noting improved financing prospects.
XRTXkidney diseaseshare consolidation